Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MK-4830 |
Synonyms | |
Therapy Description |
MK-4830 is a monoclonal antibody that targets LILRB2 (ILT4), which may relieve LILRB2 (ILT4)-mediated immunosuppression in the tumor microenvironment and enhance antitumor activity (PMID: 34598945, NCI Drug Dictionary). |